Detalles de la búsqueda
1.
Childhood cancer data initiative: Status report.
Pediatr Blood Cancer;
71(2): e30745, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37889049
2.
A review of the experience with pediatric written requests issued for oncology drug products.
Pediatr Blood Cancer;
68(2): e28828, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33245181
3.
KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study.
Haematologica;
108(10): 2865-2871, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36861410
4.
Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group.
Blood;
122(4): 507-14, 2013 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-23741010
5.
Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia.
Blood;
121(14): 2689-703, 2013 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23393050
6.
Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).
Pediatr Blood Cancer;
62(3): 419-26, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25399948
7.
Declining childhood and adolescent cancer mortality.
Cancer;
120(16): 2497-506, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24853691
8.
The Children's Oncology Group Childhood Cancer Research Network (CCRN): case catchment in the United States.
Cancer;
120(19): 3007-15, 2014 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24889136
9.
Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.
Blood;
119(8): 1872-81, 2012 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-22210879
10.
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.
Blood;
120(20): 4197-204, 2012 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23007406
11.
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.
Blood;
119(15): 3512-22, 2012 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22368272
12.
Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA).
Pediatr Blood Cancer;
61(8): 1403-10, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24648275
13.
Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries.
Lancet Oncol;
14(3): e95-e103, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23434338
14.
Pediatric Cancer Drug Development: Leveraging Insights in Cancer Biology and the Evolving Regulatory Landscape to Address Challenges and Guide Further Progress.
Cold Spring Harb Perspect Med;
14(4)2024 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38467448
15.
Review of Racial and Ethnic Representation of Participants Enrolled in Pediatric Clinical Trials of Oncology Drugs Conducted Through FDA Written Requests.
JAMA Oncol;
10(3): 380-383, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175622
16.
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood;
118(11): 3080-7, 2011 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21680795
17.
Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.
Blood;
118(17): 4561-6, 2011 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-21873548
18.
Fine-Tuning the Relevance of Molecular Targets to Pediatric Cancer: Addressing Additional Layers of Complexity.
Clin Pharmacol Ther;
113(5): 957-959, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36219676
19.
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer.
J Clin Oncol;
41(24): 4045-4053, 2023 08 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37267580
20.
CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia.
Br J Haematol;
156(1): 89-98, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22017452